Jeffrey L Radke
CEO at Accelerant Holdings (ARX)
Purchase track record
Not enough history. Based on 1 purchase with a full 90 days of price history.
—
Avg. 90-day return-23.5%
vs. S&P 500-27.3%
Beat the market0%
Paper profit on buys+$468K
Total bought / sold$999K / $8.8M
Reported trades
| Filed | Stock | Type | Shares | Price | Value | Since |
|---|---|---|---|---|---|---|
| Aug 11SEC | ARXAccelerant Holdings | Sell Plan | 80,00027,591,939 held (−0%) | $12.09 | $967K | +63.8% |
| Aug 4SEC | ARXAccelerant Holdings | Sell Plan | 80,00027,671,939 held (−0%) | $12.06 | $965K | +64.2% |
| Jul 28SEC | ARXAccelerant Holdings | Sell Plan | 80,00027,767,162 held (−0%) | $14.63 | $1.2M | +35.3% |
| Jul 28SEC | ARXAccelerant Holdings | Sell Plan | 15,22327,751,939 held (−0%) | $14.45 | $220K | +37.0% |
| Jul 20SEC | ARXAccelerant Holdings | Sell Plan | 14,77727,927,162 held (−0%) | $14.30 | $211K | +38.5% |
| Jul 20SEC | ARXAccelerant Holdings | Sell Plan | 80,00027,847,162 held (−0%) | $13.51 | $1.1M | +46.6% |
| Jul 14SEC | ARXAccelerant Holdings | Sell Plan | 80,00027,941,939 held (−0%) | $13.18 | $1.1M | +50.2% |
| Jul 7SEC | ARXAccelerant Holdings | Sell Plan | 80,00028,021,939 held (−0%) | $13.33 | $1.1M | +48.5% |
| Jun 30SEC | ARXAccelerant Holdings | Sell Plan | 80,00028,101,939 held (−0%) | $12.87 | $1.0M | +53.8% |
| Jun 25SEC | ARXAccelerant Holdings | Sell Plan | 80,00028,181,939 held (−0%) | $13.11 | $1.0M | +51.0% |
| Nov 18SEC | ARXAccelerant Holdings | Buy | 74,11028,261,939 held (+0%) | $13.48 | $999K | +46.9% |
- Sell
CEO Jeffrey L Radke sold $967K of ARX at $12.09 — pre-scheduled 10b5-1 plan sale.
- Sell
CEO Jeffrey L Radke sold $965K of ARX at $12.06 — pre-scheduled 10b5-1 plan sale.
- Sell
CEO Jeffrey L Radke sold $1.2M of ARX at $14.63 — pre-scheduled 10b5-1 plan sale.
- Sell
CEO Jeffrey L Radke sold $220K of ARX at $14.45 — pre-scheduled 10b5-1 plan sale.
- Sell
CEO Jeffrey L Radke sold $211K of ARX at $14.30 — pre-scheduled 10b5-1 plan sale.
- Sell
CEO Jeffrey L Radke sold $1.1M of ARX at $13.51 — pre-scheduled 10b5-1 plan sale.